TrialJournal of thrombosis and thrombolysis2000

High platelet count in platelet-rich plasma reduces measured platelet inhibition by abciximab but not tirofiban nor eptifibatide glycoprotein IIb/IIIa receptor antagonists.

D J Kereiakes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.